Ziprasidone, an antipsychotic drug, is indicated for the treatment of schizophrenia and bipolar disorder. The FDA approval regards the ziprasidone hydrochloride capsules in 20mg, 40mg, 60mg and 80mg
The company said that data from the placebo-controlled trial, which studied healthy adult males, aged 21 to 45, demonstrated biochemical evidence of dopamine blockade, which is indicative of
The results of the continuation PRECiSE 3 study showed that at 80 weeks, more than 85% of the patient subgroup who continuously received Cimzia 400mg subcutaneously every four
Celgene said that in the placebo-controlled phase II study of CC-10004, the drug showed significant activity and an excellent side effect profile in patients with moderate-to-severe psoriasis. Indeed,
Dendreon is currently awaiting FDA approval of its Provenge treatment, but a negative letter from the US regulator looked likely to delay the drug's authorization, which prompted Dendreon
The New England Journal of Medicine has published a study reporting a 43% increase in the risk of heart attacks in people taking Avandia and potentially a 64%
NKTR-061 (inhaled amikacin) is an inhaled antibiotic product candidate that uses the company's micropump technology to rapidly deliver aerosolized antibiotics to the deep lungs, both within and outside
The company said that in a substantial subset of patients at intermediate risk for disease recurrence, the phase III drug demonstrated a clinically significant improvement in recurrence-free survival
NOV-002, which is currently in trials for oncology indications, will be part of the National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases’ (NIAID)
According to AstraZeneca, the new version of its Seroquel treatment is designed to make the administration of the schizophrenia drug easier to manage. The previous Seroquel treatment had
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.